Treatment of hyperprostaglandin E syndrome with indomethacin.
Bétend
B
B
David
L
L
D000293:Adolescent; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000378:metabolism; D002128:Calcium Metabolism Disorders / Q000188:drug therapy / Q000378:metabolism; D002648:Child; D015232:Dinoprostone / Q000378:metabolism*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007223:Infant; D009397:Nephrocalcinosis / Q000188:drug therapy / Q000378:metabolism; D006831:Polyhydramnios / Q000188:drug therapy / Q000378:metabolism; D013577:Syndrome
D015232:Dinoprostone; D007213:Indomethacin